The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F20%3A00115894" target="_blank" >RIV/00216224:14110/20:00115894 - isvavai.cz</a>
Alternative codes found
RIV/65269705:_____/20:00072850
Result on the web
<a href="https://academic.oup.com/ibdjournal/article/26/7/985/5721205" target="_blank" >https://academic.oup.com/ibdjournal/article/26/7/985/5721205</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/ibd/izaa009" target="_blank" >10.1093/ibd/izaa009</a>
Alternative languages
Result language
angličtina
Original language name
The Emerging Role of Noncoding RNAs in Pediatric Inflammatory Bowel Disease
Original language description
Prevalence of inflammatory bowel disease (IBD), a chronic inflammatory disorder of the gut, has been on the rise in recent years—not only in the adult population but also especially in pediatric patients. Despite the absence of curative treatments, current therapeutic options are able to achieve long-term remission in a significant proportion of cases. To this end, however, there is a need for biomarkers enabling accurate diagnosis, prognosis, and prediction of response to therapies to facilitate a more individualized approach to pediatric IBD patients. In recent years, evidence has continued to evolve concerning noncoding RNAs (ncRNAs) and their roles as integral factors in key immune-related cellular pathways. Specific deregulation patterns of ncRNAs have been linked to pathogenesis of various diseases, including pediatric IBD. In this article, we provide an overview of current knowledge on ncRNAs, their altered expression profiles in pediatric IBD patients, and how these are emerging as potentially valuable clinical biomarkers as we enter an era of personalized medicine.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30219 - Gastroenterology and hepatology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Inflammatory Bowel Diseases
ISSN
1078-0998
e-ISSN
1536-4844
Volume of the periodical
26
Issue of the periodical within the volume
7
Country of publishing house
US - UNITED STATES
Number of pages
9
Pages from-to
985-993
UT code for WoS article
000544164200014
EID of the result in the Scopus database
2-s2.0-85086746607